Incyte Corporation (INCY)
56.80
-1.41 (-2.42%)
At close: Apr 21, 2025, 3:59 PM
57.45
1.14%
After-hours: Apr 21, 2025, 05:52 PM EDT
Incyte Revenue Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Dec 31, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I C L U S I G Revenue | 29.75M | 26.86M | 30.34M | 27.72M | 29.09M | 27.68M | 27.62M | 25.93M | 26.22M | 26.07M | n/a | 28.52M | 28.19M | 25.64M | 110M | 26.38M | 22.8M | 27.25M | n/a | 20.61M | 24.39M | 20.64M | 60M | 20.1M | 19.9M | 20.8M | 182M | 106M | 72.8M | 43.3M | 9M | 2M |
| I C L U S I G Revenue Growth | +10.73% | -11.47% | +9.46% | -4.70% | +5.06% | +0.25% | +6.51% | -1.12% | +0.59% | n/a | -100.00% | +1.18% | +9.92% | -76.69% | +316.98% | +15.71% | -16.33% | n/a | -100.00% | -15.50% | +18.18% | -65.60% | +198.51% | +1.01% | -4.33% | -88.57% | +71.70% | +45.60% | +68.13% | +381.11% | +350.00% | n/a |
| J A K A F I Revenue | 115.74M | 99.32M | 89.59M | 732.8M | 772.83M | 656.66M | 738.68M | 705.4M | 681.38M | 615.33M | n/a | 642.03M | 611.09M | 531.31M | n/a | 556.09M | 539.92M | 515.81M | n/a | 491.83M | 466.4M | 421.18M | n/a | 398.5M | 392.7M | 313.7M | n/a | n/a | n/a | n/a | n/a | n/a |
| J A K A F I Revenue Growth | +16.54% | +10.85% | -87.77% | -5.18% | +17.69% | -11.10% | +4.72% | +3.53% | +10.73% | n/a | -100.00% | +5.06% | +15.02% | n/a | n/a | +2.99% | +4.67% | n/a | n/a | +5.45% | +10.74% | n/a | n/a | +1.48% | +25.18% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| M I N J U V I Revenue | 31.44M | 31.12M | 23.87M | 8.35M | 13.16M | 6.56M | 4.81M | 5.93M | 4.41M | 4.5M | 67.97M | 556K | 10M | 32.26M | n/a | 95M | 95M | 25.45M | n/a | 17.5M | 20M | 40M | n/a | 20M | 100M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| M I N J U V I Revenue Growth | +1.04% | +30.33% | +185.98% | -36.56% | +100.72% | +36.33% | -18.93% | +34.48% | -2.02% | -93.38% | +12125.72% | -94.44% | -69.00% | n/a | n/a | 0.00% | +273.32% | n/a | n/a | -12.50% | -50.00% | n/a | n/a | -80.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Milestone And Contract Revenue Revenue | 18M | n/a | 25M | 29.61M | 32.01M | n/a | 160M | 20.37M | 16.56M | 5M | 50M | 35M | 36.05M | 13.46M | n/a | 28.65M | 25.83M | n/a | n/a | 21.64M | 19.14M | 16.04M | n/a | 11M | 8.9M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Milestone And Contract Revenue Revenue Growth | n/a | -100.00% | -15.58% | -7.48% | n/a | -100.00% | +685.43% | +23.01% | +231.20% | -90.00% | +42.86% | -2.90% | +167.87% | n/a | n/a | +10.91% | n/a | n/a | n/a | +13.08% | +19.35% | n/a | n/a | +23.60% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Olumiant Royalty Revenue | 34.8M | 31.7M | 30.59M | 91.84M | 80.23M | 34.16M | 114.18M | 38.14M | 18.98M | 12.75M | 66M | 86.57M | 17.91M | 2.05M | n/a | 8.09M | 3.79M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Olumiant Royalty Revenue Growth | +9.76% | +3.64% | -66.69% | +14.46% | +134.91% | -70.09% | +199.36% | +100.92% | +48.84% | -80.68% | -23.76% | +383.48% | +774.74% | n/a | n/a | +113.66% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| OPZELURA Revenue | 139.27M | 121.69M | 85.72M | 19.46M | 21.92M | 56.55M | 61.28M | 23.41M | 3.58M | 18.03M | 60.47M | 17.56M | 2.48M | n/a | n/a | 1.44M | 706K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| OPZELURA Revenue Growth | +14.44% | +41.96% | +340.40% | -11.20% | -61.24% | -7.72% | +161.73% | +553.84% | -80.14% | -70.18% | +244.33% | +609.29% | n/a | n/a | n/a | +103.68% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PEMAZYRE Royalty Revenues Revenue | 21.07M | 21.14M | 18.22M | 4.14M | 4.8M | 22.89M | 24.22M | 4.11M | n/a | 3.48M | 3.12M | 2.75M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PEMAZYRE Royalty Revenues Revenue Growth | -0.33% | +16.03% | +340.30% | -13.75% | -79.03% | -5.51% | +488.75% | n/a | n/a | +11.67% | +13.54% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Tabrecta Royalty Revenues Revenue | 5.93M | 5.3M | 5.23M | 98K | 570K | 4.18M | 4.23M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Tabrecta Royalty Revenues Revenue Growth | +11.89% | +1.22% | +5240.82% | -82.81% | -86.35% | -1.32% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| ZYNYZ Revenue | 694K | 651K | 467K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| ZYNYZ Revenue Growth | +6.61% | +39.40% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|
| Europe Revenue | 147M | 124.1M | 105M | 90M | 79.9M | 66.9M | 29.6M |
| Europe Revenue Growth | +18.45% | +18.19% | +16.67% | +12.64% | +19.43% | +126.01% | n/a |
| United States Revenue | 3.2B | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 326.8M | 309.2M | 289.63M | 300.3M | 293.9M | 267.89M | 283.9M | 315.61M | 272.82M | 266.5M | 253.28M | 209.58M | 226.2M | 190.7M | 168.9M | 153.79M | 166.99M | 120.8M | 118M | 111.15M | 136.18M | 102.61M | 105.94M | 123.98M | 108.36M | 96.52M | 108.03M | 121.5M | 97.83M | 91.27M | 90.07M | 87.23M | 96.08M | 75.78M | 66.79M | 64.6M | 52.47M | 47.6M | 51.68M | 44.87M |
| Selling, General, and Administrative Revenue Growth | +5.69% | +6.76% | -3.55% | +2.18% | +9.71% | -5.64% | -10.05% | +15.68% | +2.37% | +5.22% | +20.85% | -7.35% | +18.62% | +12.91% | +9.82% | -7.90% | +38.24% | +2.37% | +6.16% | -18.38% | +32.72% | -3.15% | -14.55% | +14.42% | +12.26% | -10.65% | -11.09% | +24.19% | +7.19% | +1.33% | +3.25% | -9.21% | +26.80% | +13.45% | +3.40% | +23.12% | +10.23% | -7.89% | +15.17% | n/a |
| Research and Development Revenue | 466.03M | 573.17M | 1.14B | 429.26M | 444.49M | 375.71M | 400.75M | 406.64M | 501.36M | 384.01M | 347.2M | 353.37M | 472.83M | 334.94M | 343.51M | 306.9M | 405.94M | 438.11M | 286.6M | 1.09B | 312.87M | 281.34M | 289.36M | 270.55M | 304.24M | 292.53M | 298.09M | 303.1M | 446.94M | 269.61M | 201.84M | 407.97M | 161.59M | 143.18M | 120.27M | 156.82M | 116.63M | 132.07M | 112.44M | 118.36M |
| Research and Development Revenue Growth | -18.69% | -49.65% | +165.20% | -3.43% | +18.31% | -6.25% | -1.45% | -18.89% | +30.56% | +10.60% | -1.75% | -25.26% | +41.17% | -2.49% | +11.93% | -24.40% | -7.34% | +52.86% | -73.59% | +246.88% | +11.21% | -2.77% | +6.96% | -11.07% | +4.00% | -1.87% | -1.65% | -32.18% | +65.77% | +33.58% | -50.53% | +152.48% | +12.85% | +19.05% | -23.31% | +34.46% | -11.69% | +17.46% | -5.00% | n/a |